Clinical Study
Hypertension Control and Cardiometabolic Risk: A Regional Perspective
Table 8
Blood pressure and triglycerides (mmol/L ± SD, adjusted for age, gender, and diabetes).
| | Total () | Northern Europe () | Southern Europe () | North America () | Middle East () | Asia () | value |
| SBP (mmHg) | | | | | | | | <120 | 1.5 (0.037) | 1.6 (0.078) | 1.6 (0.068) | 1.5 (0.102) | 1.3 (0.206) | 1.7 (0.076) | 0.4212 | 120–139 | 1.7 (0.017) | 1.8 (0.033) | 1.6 (0.027) | 1.8 (0.054) | 1.7 (0.120) | 1.8 (0.038) | <0.0001 | 140–159 | 1.8 (0.014) | 1.9 (0.025) | 1.7 (0.023) | 1.7 (0.054) | 2.1 (0.075) | 1.9 (0.036) | <0.0001 | 160–179 | 1.9 (0.020) | 2.0 (0.033) | 1.8 (0.033) | 1.7 (0.085) | 2.2 (0.082) | 2.0 (0.055) | <0.0001 | ≥180 | 1.9 (0.034) | 2.0 (0.055) | 1.8 (0.057) | 1.9 (0.157) | 2.3 (0.134) | 2.2 (0.097) | 0.0054 | value | <0.0001 | <0.0001 | <0.0001 | 0.1658 | 0.0039 | 0.0008 | | DBP (mmHg) | | | | | | | | <90 | 1.7 (0.012) | 1.8 (0.021) | 1.6 (0.020) | 1.7 (0.037) | 1.7 (0.078) | 1.8 (0.028) | <0.0001 | 90–99 | 1.9 (0.016) | 2.0 (0.028) | 1.8 (0.026) | 1.9 (0.074) | 2.2 (0.073) | 1.9 (0.042) | <0.0001 | 100–109 | 1.9 (0.027) | 2.0 (0.050) | 1.8 (0.044) | 2.0 (0.154) | 2.3 (0.108) | 2.1 (0.073) | <0.0001 | ≥110 | 1.9 (0.053) | 1.8 (0.089) | 1.9 (0.084) | 1.9 (0.342) | 2.4 (0.180) | 2.3 (0.161) | 0.0073 | value | <0.0001 | <0.0001 | <0.0001 | 0.0469 | 0.0012 | <0.0001 | | RR (mmHg) | | | | | | | | uncontrolled* | 1.9 (0.014) | 2.0 (0.018) | 1.7 (0.017) | 1.8 (0.043) | 2.1 (0.050) | 1.9 (0.028) | <0.0001 | controlled** | 1.7 (0.011) | 1.7 (0.033) | 1.6 (0.027) | 1.7 (0.050) | 1.7 (0.115) | 1.8 (0.037) | 0.0024 | value | <0.0001 | <0.0001 | <0.0001 | 0.4255 | 0.0025 | 0.0081 | |
|
|
*SBP/DBP ≥140/90 in non-diabetic and ≥130/80 in diabetic patients, **<140/90 in non-diabetic and <130/80 in diabetic patients.
|